Introducing new technology into clinical trial workflows may seem technically complex, but it doesn’t have to be. While most could assume that this transitional period faces challenges related to technical implementation, most clinical trial organizations report that motivating user adoption of the solution is the real obstacle.
That said, some sites find resistance from clinical trial staff uneasy with moving to a new way of doing things. Even if it’s more comfortable to use, transitioning from traditional paper and fragmented technology workflows to a fully electronic and purpose-built eRegulatory platform can have its share of challenges—no matter how many benefits may be offered.
Gain insight from this collection of best practices when selecting and evaluating an eRegulatory solution.